Vetter Plans Expansion in Illinois
PTSM: Pharmaceutical Technology Sourcing and Management
The company plans to purchase and develop an 18-acre site in Des Plaines, Illinois.
During a meeting held on July 12, 2016, Vetter Pharma shared its potential plan to purchase and develop an 18-acre site located in Des Plaines, Illinois. According to the company, the intention of this expansion is to offer its global customer base a US manufacturing opportunity.
For this project, Vetter plans to invest approximately $320 million in construction and site improvements in a more than 10-year period. Once it has reached its final expansion stage, the 18-acre site would include 1,138,237 square feet of facility space. If approved, the facility would be the company’s second US manufacturing site. The Des Plaines facility would lead to the possible creation of between 400–500 jobs by the final expansion stage, Vetter noted.
Source: Vetter Pharma
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
